Target intelligence / Profile preview

Long intergenic non-protein coding RNA 254 (LINC00254)

Target
LINC00254
Molecular classification
Long intergenic non-coding RNA, Non-coding RNA, lincRNA, lncRNA
01

Overview

Long intergenic non-protein coding RNA 254 (LINC00254) is a member of the long intergenic non-coding RNA (lincRNA) family. It does not encode a protein product and produces RNA transcripts longer than 200 nucleotides, which are transcribed from intergenic regions of the genome—regions that do not overlap annotated protein-coding loci[1][3][5]. LINC00254 is thought to have regulatory roles, including the fine-tuning of neighboring gene expression, chromatin remodeling, and possibly acting as a scaffold for chromatin-modifying complexes[5][7]. Like other lincRNAs, LINC00254 may exert effects on gene expression in a tissue- or context-specific manner, and altered expression of lincRNAs has been associated with diseases such as cancer, but specific, robust mechanistic and clinical data for LINC00254 remain sparse[4][5][7]. There is no evidence that LINC00254 is a direct therapeutic target (e.g., receptor, enzyme) or that any drugs bind or modulate it directly.

Other names
C16orf32NCRNA00254LINC00254
02

Biological functions

Gene regulationChromatin remodelingRNA stabilizationTranscriptional regulationPotential enhancer activity
03

Disease associations

CancerOther (potential roles in gene expression and tissue specificity, but specific disease links are limited in current literature)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 254 (LINC00254).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 254 (LINC00254).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call